Bibliography
- SHANAFELT AB, UN Y, SHANAFELT MC et al.: AT cell-selective IL-2 mutein exhibits potent antitumour activity and is well-tolerated in vivo. Nat. Biotech. (2000) 18(11):1197–1202.
- BAERT F, NOMAN M, VERMEIRE S et al.: Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N EngL J. Med. (2003) 348:601–608.
- CEFALU WT: Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care (2004) 27:239–246.